首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Sodium citrate and potassium phosphate as alternative adsorption buffers in hydrophobic and aromatic thiophilic chromatographic purification of plasmid DNA from neutralized lysate
【24h】

Sodium citrate and potassium phosphate as alternative adsorption buffers in hydrophobic and aromatic thiophilic chromatographic purification of plasmid DNA from neutralized lysate

机译:柠檬酸钠和磷酸钾作为疏水吸附和芳香族亲硫色谱法从中和的裂解物中纯化质粒DNA的替代吸附缓冲液

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The number of studies on gene therapy using plasmid vectors (pDNA) has increased in recent years. As a result, the demand for preparations of pDNA in compliance with recommendations of regulatory agencies (EMEA, FDA) has also increased. Plasmid DNA is often obtained through fermentation of transformed Escherichia coli and purification by a series of unit operations, including chromatography. Hydrophobic interaction chromatography (HIC) and thiophilic aromatic chromatography (TAC), both using ammonium sulfate buffers, are commonly employed with success. This work was aimed at studying the feasibility of utilizing alternative salts in the purification of pDNA from neutralized lysate with phenyl-agarose (HIC) and mercaptopyrimidine-agarose (TAC) adsorbents. Their selectivity toward sc pDNA was evaluated through adsorption studies using 1.5. mol/L sodium citrate and 2.0. mol/L potassium phosphate as adsorption buffers. Chromatography with mercaptopyrimidine-agarose adsorbent and 1.5. mol/L sodium citrate was able to recover 91.1% of the pDNA with over 99.0% removal of gDNA and endotoxin. This represents a potential alternative for the primary recovery of sc pDNA. However, the most promising result was obtained using 2.0. mol/L potassium phosphate buffer and a mercaptopyrimidine-agarose column. In a single chromatographic step, this latter buffer/adsorbent system recovered 68.5% of the pDNA with 98.8% purity in accordance with the recommendations of regulatory agencies with regard to RNA and endotoxin impurity.
机译:近年来,使用质粒载体(pDNA)进行基因治疗的研究数量有所增加。结果,对符合监管机构(EMEA,FDA)建议的pDNA制备的需求也增加了。质粒DNA通常是通过转化大肠杆菌的发酵并通过一系列的单元操作(包括色谱法)纯化而获得的。均使用硫酸铵缓冲液的疏水相互作用色谱法(HIC)和亲硫芳香族色谱法(TAC)通常得到成功使用。这项工作旨在研究使用替代盐在用苯基琼脂糖(HIC)和巯基嘧啶-琼脂糖(TAC)吸附剂从中和的裂解物中纯化pDNA的可行性。通过使用1.5的吸附研究评估了它们对sc pDNA的选择性。 mol / L柠檬酸钠和2.0。 mol / L磷酸钾作为吸附缓冲剂。用巯基嘧啶-琼脂糖吸附剂和1.5层析。 mol / L柠檬酸钠能够回收91.1%的pDNA,而gDNA和内毒素的去除率超过99.0%。这代表了sc pDNA的初步回收的潜在替代方法。但是,使用2.0获得了最有希望的结果。 mol / L磷酸钾缓冲液和巯基嘧啶-琼脂糖柱。在单个色谱步骤中,根据监管机构关于RNA和内毒素杂质的建议,后一种缓冲液/吸附剂系统回收了68.5%的pDNA,纯度为98.8%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号